Dr.Manmohan Singh is currently heading the Pharmaceutical Sciences and Delivery Group at Beam Therapeutics in Cambridge, MA. Dr. Singh has over 25 years of R&D experience in drug product development, novel delivery systems and vaccine research. He previously led technical teams overseeing early stage vaccine development programs all the way to commercial manufacturing at Takeda and Novartis. His team was instrumental in approval of several novel vaccines (FluAd®,Bexsero®,Menveo®,Flucelvax®). Dr. Singh has authored over 120 peer reviewed papers and is the editor of 6 Books on vaccines and drug product development. He was elected as a Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2011.